LearnSkin

Management of Inflammatory Diseases: Psoriasis and Seborrheic Dermatitis

Seborrheic Dermatitis 101: Pathophysiology and Clinical Associations

1 CME Credit1 Lesson
592 Enrolled

Course Overview

Preview what you'll learn in this program

0hr 55min
Duration
1
Credit
Dec 2023
Released
Mar 2026
Expires
85% avg
Completion

What You'll Learn

Seborrheic dermatitis is prevalent in the general population and is associated with multiple conditions and disease states. Specific climates and clothing (such as masks) are associated with seborrheic dermatitis and will be discussed.

Target Audience

This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with seborrheic dermatitis.

Disclosure of Conflicts of Interest

Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of FacultyReported Financial Relationship

Brad Glick, DO MPH FAAD

Advisory Board/Consultant: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Janssen Pharmaceuticals; Galderma; LEO Pharma; Eli Lilly and Company; Novartis; Incyte; Dermira, Inc.; Sanofi Genzyme; Regeneron Pharmaceuticals, Inc.; Pfizer Inc.; Ortho Dermatologics; UCB 
Investigator: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; AstraZeneca; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Bellus Medical; Galderma; Eli Lilly and Company; Nimbus Lakshmi, Inc; Cara Therapeutics; Dermira, Inc.; ChemoCentryx; Brickell Biotech, Inc.; CorEvitas Registry PSO; CorEvitas Registry AD; PROSE Registry for AD 
Speaker: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Janssen Pharmaceuticals; Eli Lilly and Company; Novartis; Incyte; Dermira, Inc.; Sanofi Genzyme; Regeneron Pharmaceuticals, Inc.; Pfizer Inc.; Ortho Dermatologics; UCB

Stock Holder: Top MD

Name of Editor/Scientific Reviewer

Reported Financial Relationship

Jason E. Hawkes, MD MS

Advisory Board/Consultant: AbbVie, Arcutis, Boehringer-Ingelheim, BMS, Janssen, LEO, Lilly, Novartis, Pfizer, Regeneron-Sanofi Genzyme, UCB
Medical/Scientific board: Medical Board, National Psoriasis Foundation (NPF), Scientific Advisory Committee, National Psoriasis Foundation (NPF), Councilor, International Psoriasis Council (IPC)
Stock Ownership/Equity: Regeneron Pharmaceuticals (Spouse, employment)

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity: 

Name of Content ManagerReported Financial Relationship

Jason E. Hawkes, MD MS

Advisory Board/Consultant: AbbVie, Arcutis, Boehringer-Ingelheim, BMS, Janssen, LEO, Lilly, Novartis, Pfizer, Regeneron-Sanofi Genzyme, UCB

Medical/Scientific board: Medical Board, National Psoriasis Foundation (NPF), Scientific Advisory Committee, National Psoriasis Foundation (NPF), Councilor, International Psoriasis Council (IPC)

Stock Ownership/Equity: Regeneron Pharmaceuticals (Spouse, employment)

Planners at Your CE Source

No financial relationships to disclose

All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and LearnHealth. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Your CE Source designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

This CE activity provides 1 contact hour of continuing nursing education. Your CE Source is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031.

Method of Participation

Participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the post test by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.

Disclaimer

The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of Arcutis, Dermavant, Your CE Source and/or LearnHealth. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see the policy at https://www.yourcesource.org

Contact Information

This activity is jointly provided by Your CE Source and LearnHealth.

Questions about CE accreditation or CE certificates related to this course, please contact us via email at [email protected] . For all other questions, please contact [email protected].

Faculty

User: Brad Glick
Brad Glick
DO MPH FAAD

Editors

User: jasonhawkes@learnskin.com
Jason Hawkes
MD, MS, FAAD

Accreditation Information

Seborrheic dermatitis is prevalent in the general population and is associated with multiple conditions and disease states. Specific climates and clothing (such as masks) are associated with seborrheic dermatitis and will be discussed.

Target Audience

This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with seborrheic dermatitis.

Disclosure of Conflicts of Interest

Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of FacultyReported Financial Relationship

Brad Glick, DO MPH FAAD

Advisory Board/Consultant: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Janssen Pharmaceuticals; Galderma; LEO Pharma; Eli Lilly and Company; Novartis; Incyte; Dermira, Inc.; Sanofi Genzyme; Regeneron Pharmaceuticals, Inc.; Pfizer Inc.; Ortho Dermatologics; UCB 
Investigator: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; AstraZeneca; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Bellus Medical; Galderma; Eli Lilly and Company; Nimbus Lakshmi, Inc; Cara Therapeutics; Dermira, Inc.; ChemoCentryx; Brickell Biotech, Inc.; CorEvitas Registry PSO; CorEvitas Registry AD; PROSE Registry for AD 
Speaker: AbbVie, Amgen Inc.; Arcutis Biotherapeutics; Sun Pharmaceutical Industries; Dermavant Sciences, Inc.; Bristol-Myers Squibb; Janssen Pharmaceuticals; Eli Lilly and Company; Novartis; Incyte; Dermira, Inc.; Sanofi Genzyme; Regeneron Pharmaceuticals, Inc.; Pfizer Inc.; Ortho Dermatologics; UCB

Stock Holder: Top MD

Name of Editor/Scientific Reviewer

Reported Financial Relationship

Jason E. Hawkes, MD MS

Advisory Board/Consultant: AbbVie, Arcutis, Boehringer-Ingelheim, BMS, Janssen, LEO, Lilly, Novartis, Pfizer, Regeneron-Sanofi Genzyme, UCB
Medical/Scientific board: Medical Board, National Psoriasis Foundation (NPF), Scientific Advisory Committee, National Psoriasis Foundation (NPF), Councilor, International Psoriasis Council (IPC)
Stock Ownership/Equity: Regeneron Pharmaceuticals (Spouse, employment)

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity: 

Name of Content ManagerReported Financial Relationship

Jason E. Hawkes, MD MS

Advisory Board/Consultant: AbbVie, Arcutis, Boehringer-Ingelheim, BMS, Janssen, LEO, Lilly, Novartis, Pfizer, Regeneron-Sanofi Genzyme, UCB

Medical/Scientific board: Medical Board, National Psoriasis Foundation (NPF), Scientific Advisory Committee, National Psoriasis Foundation (NPF), Councilor, International Psoriasis Council (IPC)

Stock Ownership/Equity: Regeneron Pharmaceuticals (Spouse, employment)

Planners at Your CE Source

No financial relationships to disclose

All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and LearnHealth. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Your CE Source designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

This CE activity provides 1 contact hour of continuing nursing education. Your CE Source is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031.

Method of Participation

Participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the post test by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the evaluation form is completed.

Disclaimer

The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of Arcutis, Dermavant, Your CE Source and/or LearnHealth. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see the policy at https://www.yourcesource.org

✨ Ready to Begin Your Journey? ✨

Enroll now to start the course and unlock all learning materials

Login

Pre-Quiz

Test your knowledge before starting the course

Questions
3
Average Score
49%
Lesson 10hr 44min

Seborrheic Dermatitis 101: Pathophysiology and Clinical Associations

Complete the previous section to unlock this lesson

Post-Quiz

Asess your learning and review your progress

Questions
3
Passing Score
70%
Average Score
85%

Course Evaluation

Complete the post-quiz to unlock the course evaluation

CME Certificate

1 CME Credit

Complete Requirements to Unlock

Finish the post-quiz and course evaluation to receive your certificate

  • Complete all lessons
  • Pass post-quiz (70% or higher)
  • Submit course evaluation

Course Discussion

Join the conversation with fellow learners

Continue Your Learning Journey

Next course in Management of Inflammatory Diseases: Psoriasis and Seborrheic Dermatitis

Course: Management of Severe Generalized Psoriasis in a Female Patient
Next in Series
Course in series

Management of Severe Generalized Psoriasis in a Female Patient

Review case management skills in this case-based microlearning course featuring a female patient with severe generalized psoriasis.

CME
Start Next Course
LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2026.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!